Phase I study of Pomolidomide, Bortezomib, and Dexamethasone (PVD) as First-Line treatment of AL Amyloidosis or Light Chain Deposition Disease
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Karmanos Cancer Center
Start Date
June 1, 2014
End Date
December 1, 2021
Administered By
Duke Cancer Institute
Awarded By
Karmanos Cancer Center
Start Date
June 1, 2014
End Date
December 1, 2021